Ralph Mösges

11.4k total citations
213 papers, 4.2k citations indexed

About

Ralph Mösges is a scholar working on Immunology and Allergy, Physiology and Dermatology. According to data from OpenAlex, Ralph Mösges has authored 213 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 138 papers in Immunology and Allergy, 98 papers in Physiology and 46 papers in Dermatology. Recurrent topics in Ralph Mösges's work include Allergic Rhinitis and Sensitization (138 papers), Asthma and respiratory diseases (94 papers) and Dermatology and Skin Diseases (41 papers). Ralph Mösges is often cited by papers focused on Allergic Rhinitis and Sensitization (138 papers), Asthma and respiratory diseases (94 papers) and Dermatology and Skin Diseases (41 papers). Ralph Mösges collaborates with scholars based in Germany, United Kingdom and United States. Ralph Mösges's co-authors include Ludger Klimek, Oliver Pfaar, Kija Shah‐Hosseini, J. Sastre, Karl Hörmann, Jean Bousquet, Martin Hellmich, Juliane Köberlein–Neu, Grigore Burdea and Russell H. Taylor and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Allergy and Clinical Immunology.

In The Last Decade

Ralph Mösges

204 papers receiving 3.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ralph Mösges 2.2k 1.9k 938 819 768 213 4.2k
Cemal Cingi 1.2k 0.5× 1.3k 0.7× 962 1.0× 504 0.6× 794 1.0× 229 3.5k
Desiderio Passàli 1.4k 0.6× 1.6k 0.8× 1.3k 1.4× 240 0.3× 1.2k 1.6× 245 4.5k
Ludger Klimek 4.9k 2.2× 3.9k 2.0× 1.2k 1.3× 1.8k 2.2× 1.1k 1.4× 516 8.7k
Jeong‐Whun Kim 580 0.3× 1.7k 0.9× 784 0.8× 95 0.1× 674 0.9× 187 3.7k
Andrew P. Lane 968 0.4× 983 0.5× 1.2k 1.3× 61 0.1× 1.6k 2.1× 161 4.7k
Ahmad R. Sedaghat 1.5k 0.7× 726 0.4× 1.8k 1.9× 56 0.1× 2.1k 2.7× 210 5.7k
Peter W. Hellings 7.0k 3.2× 7.1k 3.8× 2.8k 3.0× 1.3k 1.6× 4.4k 5.7× 320 13.1k
Peter H. Hwang 1.3k 0.6× 943 0.5× 4.4k 4.7× 117 0.1× 4.5k 5.8× 275 7.2k
Seok Hyun Cho 396 0.2× 981 0.5× 809 0.9× 95 0.1× 557 0.7× 125 2.7k
J. Christian Virchow 1.5k 0.7× 4.0k 2.1× 507 0.5× 491 0.6× 53 0.1× 176 8.0k

Countries citing papers authored by Ralph Mösges

Since Specialization
Citations

This map shows the geographic impact of Ralph Mösges's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph Mösges with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph Mösges more than expected).

Fields of papers citing papers by Ralph Mösges

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph Mösges. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph Mösges. The network helps show where Ralph Mösges may publish in the future.

Co-authorship network of co-authors of Ralph Mösges

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph Mösges. A scholar is included among the top collaborators of Ralph Mösges based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph Mösges. Ralph Mösges is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pfaar, Oliver, Ralph Mösges, Michael S. Blaiss, et al.. (2025). The Minimal Clinically Important Difference in Allergen Immunotherapy: An Evidence‐Based Approach. Allergy. 80(12). 3369–3376.
2.
Buttini, Francesca, et al.. (2024). Clinically Relevant Characterization and Comparison of Ryaltris and Other Anti-Allergic Nasal Sprays. Pharmaceutics. 16(8). 989–989. 4 indexed citations
3.
Mösges, Ralph, E Raskopf, Ludger Klimek, et al.. (2024). Short‐course subcutaneous treatment with birch pollen allergoids greatly improves symptom and medication scores in birch allergy. Allergy. 80(3). 817–826. 4 indexed citations
4.
Church, Martin K., Giorgio Walter Canonica, Piotr Kuna, et al.. (2023). An international Delphi study on the burden of allergic rhinoconjunctivitis and urticaria and the role of bilastine among current treatment options. Expert Review of Clinical Immunology. 19(7). 813–820.
5.
6.
Pieper‐Fürst, Ursula, et al.. (2022). Effectiveness of Ectoin lozenges on oropharyngeal allergic symptoms. Clinical and Translational Allergy. 12(1). e12095–e12095. 1 indexed citations
7.
Abdullah, Baharudin, Amir Hamzah Abdul Latiff, Ari Manuel, et al.. (2022). Pharmacological Management of Allergic Rhinitis: A Consensus Statement from the Malaysian Society of Allergy and Immunology. Journal of Asthma and Allergy. Volume 15. 983–1003. 14 indexed citations
8.
Pieper‐Fürst, Ursula, Cengizhan Açıkel, Hacer Sahin, et al.. (2022). Correlation of the combined symptom and medication score with quality of life, symptom severity and symptom control in allergic rhinoconjunctivitis. Clinical and Translational Allergy. 12(10). e12191–e12191. 3 indexed citations
9.
Bilstein, Andreas, et al.. (2021). Ectoine in the Treatment of Irritations and Inflammations of the Eye Surface. BioMed Research International. 2021(1). 8885032–8885032. 41 indexed citations
10.
Mösges, Ralph, Desiderio Passàli, & Mario Di Gioacchino. (2021). Worldwide surveys on anaphylaxis to sublingual immunotherapy with house dust mite tablets are urgently needed. Clinical and Translational Allergy. 11(1). e12012–e12012. 8 indexed citations
11.
Becker, Sven, Petra Zieglmayer, Gabriela Cantó, et al.. (2021). A meta‐analysis on allergen‐specific immunotherapy using MCT® (MicroCrystalline Tyrosine)‐adsorbed allergoids in pollen allergic patients suffering from allergic rhinoconjunctivitis. Clinical and Translational Allergy. 11(4). e12037–e12037. 13 indexed citations
12.
Jensen‐Jarolim, Erika, Martin F. Bachmann, С. Бонини, et al.. (2019). State‐of‐the‐art in marketed adjuvants and formulations in Allergen Immunotherapy: A position paper of the European Academy of Allergy and Clinical Immunology (EAACI). Allergy. 75(4). 746–760. 49 indexed citations
13.
Dao, Van‐Anh, et al.. (2019). Ectoine lozenges in the treatment of acute viral pharyngitis: a prospective, active-controlled clinical study. European Archives of Oto-Rhino-Laryngology. 276(3). 775–783. 23 indexed citations
14.
Pieper‐Fürst, Ursula, et al.. (2018). Alpha-tocopherol acetate nasal spray in the treatment of pollen-induced allergic rhinitis. Allergo Journal International. 28(5). 152–159. 2 indexed citations
15.
Bachert, Claus, et al.. (2015). MP29-02*provides effective AR symptom control in real life in all patient types regardless of predominant nasal symptom or presence of ocular symptoms: results from Germany. Kölner Universitäts PublikationsServer (Universität zu Köln). 1 indexed citations
16.
Mösges, Ralph, et al.. (2014). Rhinomanometric reference intervals for normal total nasal airflow resistance. Rhinology Journal. 52(4). 292–299. 21 indexed citations
17.
König, V. & Ralph Mösges. (2014). A Model for the Determination of Pollen Count Using Google Search Queries for Patients Suffering from Allergic Rhinitis. PubMed. 2014. 1–9. 20 indexed citations
18.
19.
Wedi, Bettina, T. Fuchs, Jörg Kleine‐Tebbe, Ralph Mösges, & Johannes Ring. (2004). Ebastine - review of the efficacy and safety profile of a nonsedating antihistamine. mediaTUM (Technical University of Munich). 1 indexed citations
20.
Canonica, Giorgio Walter, et al.. (1998). The impact of allergic rhinitis on quality of life and other airway diseases. Ghent University Academic Bibliography (Ghent University). 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cemal Cingi Breakdown of academic impact, for papers by Desiderio Passàli Breakdown of academic impact, for papers by Ludger Klimek Breakdown of academic impact, for papers by Jeong‐Whun Kim Breakdown of academic impact, for papers by Andrew P. Lane Breakdown of academic impact, for papers by Ahmad R. Sedaghat Breakdown of academic impact, for papers by Peter W. Hellings Breakdown of academic impact, for papers by Peter H. Hwang Breakdown of academic impact, for papers by Seok Hyun Cho Breakdown of academic impact, for papers by J. Christian Virchow
Rankless by CCL
2026